Bruker Announces SciY™ Platform of Advanced Scientific and Automation Software Solutions for the Digital Transformation of the Life Science and Biopharma Industries
30 Junho 2023 - 8:00AM
Business Wire
Bruker Corporation (Nasdaq: BRKR) today announced the
SciY™ platform of advanced, vendor-agnostic software
solutions for data analysis, data management, research lab and
bioproduction QC digitalization, and workflow automation in the
life science industry and for biopharma companies. The new
SciY platform combines and integrates high-performance lab
software solutions for a more comprehensive, vendor-agnostic suite
of software and automation solutions for life-science industry
customers, primarily in the biopharma sector.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230630514931/en/
SciY platform software companies
(Graphic: Business Wire)
SciY is being launched by Bruker’s new Integrated Data Solutions
division, in close collaboration with majority-owned software
companies Mestrelab Research, Arxspan, Optimal Industrial
Technologies and ZONTAL, along with biopharma automation company
Optimal Industrial Automation. With its innovative, modular
software solutions, the SciY product platform will streamline data
acquisition, integration and interpretation, and enhance the value
of data in life-science and biopharma research, development and
manufacturing.
SciY encompasses a software portfolio of Electronic Lab Notebook
solutions, analytical chemistry and biology solutions, Process
Analytical Technologies (PAT), and scientific data management. By
automating and digitalizing workflows for generating, analyzing,
and utilizing scientific data, customers can achieve results
faster, more cost-effectively and conveniently, enabling better and
faster decision-making, with high quality, compliance, and AI
machine-learning.
Dr. Santi Dominguez, President of the new Bruker Integrated Data
Solutions division, commented: "By developing and utilizing the
synergetic capabilities of best-in-class teams and software
products at Mestrelab, ZONTAL, Arxspan, and Optimal, our SciY
platform is reshaping research and development activities in the
biopharma and life science industries. The SciY platform of
vendor-agnostic software solutions allows the integration of our
customers’ physical laboratory instruments and automation hardware
with their scientific research, development and manufacturing data
into a digital environment to deliver maximum value with minimum
effort and disruption. We are aiming to support our clients in
their digitalization to drive seamless innovation for accelerating
the time to market for new drugs, to automate life-science lab and
manufacturing QC processes, and to support efficacy and patient
safety.”
Dr. Falko Busse, President of the Bruker BioSpin Group, added:
“With SciY and our commitment to provide instrument agnostic
software for automation, integration, innovation, and discovery, we
enable the life-science and biopharma industry collaboration,
enhance the full potential of research data, and advance the
digital transformation of the life-science industry. SciY provides
many digital end-to-end solutions for life-science research and
development, as well as manufacturing automation and QC.”
SciY is combining advanced software technologies into a set of
modular solutions to support smooth chemistry and biology
experimental design, data acquisition, integration and
interpretation, and the management of many analytical instruments,
available from various vendors.
About SciY™
SciY is a vendor-agnostic advanced platform offering a broad
range of software solutions across the life sciences research,
development and manufacturing automation and QC functions – easy to
integrate, flexible, user-centric and uncompromisingly performant.
By streamlining data analysis and management, SciY empowers
scientists and researchers, accelerates scientific discoveries and
enables precise decision-making. SciY is a brand of Bruker
Integrated Data Solution division that was born from collaborations
and majority-acquisitions of renowned vendor-agnostic software
partners. www.sciy.com
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular and cell biology research, in applied and pharma
applications, in microscopy and nanoanalysis, as well as in
industrial applications. Bruker offers differentiated, high-value
life science and diagnostics systems and solutions in preclinical
imaging, clinical phenomics research, proteomics and multiomics,
spatial and single-cell biology, functional structural and
condensate biology, as well as in clinical microbiology and
molecular diagnostics. For more information, please visit:
www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230630514931/en/
Investor: Justin Ward Sr. Director, Investor Relations
& Corporate Development Bruker Corporation T: +1 (978) 313-5800
E: Investor.Relations@bruker.com
Media: Markus Ziegler Sr. Director and Head of Group
Marketing Bruker BioSpin T: +49 172 3733531 E: pr@bruker.com
Bruker (NASDAQ:BRKR)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Bruker (NASDAQ:BRKR)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024